Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 1

Interventions

Fluorouracil 308Oxaliplatin 259Leucovorin 233Capecitabine 198Irinotecan 145Gemcitabine 127Cisplatin 126Bevacizumab 119Radiotherapy 72Paclitaxel 63Folfox protocol 56Cetuximab 56Drug Therapy 46Sorafenib 45Docetaxel 41S 1 (combination) 40Chemotherapy, Adjuvant 38Neoadjuvant Therapy 37pembrolizumab 36Surgical Procedures, Operative 27130-nm albumin-bound paclitaxel 27regorafenib 25lenvatinib 24XELOX 24Panitumumab 24Radiation 23Nivolumab 22trifluridine tipiracil drug combination 21atezolizumab 21Carboplatin 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Defecation × Gastrointestinal × Clear all
NCT01345175 2024-05-14

Rifaximin and Placebo in the Treatment of Bowel Dysfunction After Anterior Resection for Rectal Cancer

Memorial Sloan Kettering Cancer Center

Phase 3 Completed
69 enrolled 9 charts
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡